97848574 - NUCLEIX

Information

• Trademark
• 97848574

• Source

• Serial Number

  97848574

• Registration Number

  7575478

• International Classifications

  • 1 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry
  • 5 - Pharmaceutical and veterinary preparations
  • 10 - Surgical, medical, dental and veterinary apparatus and instruments, artificial limbs, eyes and teeth
  • 42 - Scientific and technological services and research and design relating thereto
  • 44 - Medical services

• Filing Date

  March 21, 2023
  2 years ago

• Registration Date

  November 26, 2024
  4 months ago

• Transaction Date

  November 26, 2024
  4 months ago

• Status Date

  November 26, 2024
  4 months ago

• Published for Opposition Date

  September 24, 2024
  6 months ago

• Location Date

  November 25, 2024
  4 months ago

• Status Code

  700

• Current Location

  FILE REPOSITORY (FRANCONIA)

  Employee Name

  JOHNSON, CLINTON

• Attorney Docket Number

  375.026817

  Attorney Name

  Jennifer Sheehan Anderson

• Owners

  • Nucleix, Ltd.

Case File Statements

• DM0000: The mark consists of the term "NUCLEIX" in a stylized format with the letter "I" inverted such that the dot appears below the word.
• GS0051: Diagnostic test kits for medical and clinical use comprised of medical diagnostic reagents for use in identifying and measuring changes associated with cancer, precancerous conditions, chronic obstructive pulmonary disease (COPD), autoimmune disease and neurological disease for testing of bodily fluids for use in disease detection, namely, cancer, precancerous conditions, chronic obstructive pulmonary disease (COPD), autoimmune disease and neurological disease; medical diagnostic assay kits comprised of medical diagnostic reagents for use in identifying and measuring changes associated with cancer, precancerous conditions, chronic obstructive pulmonary disease (COPD) autoimmune disease and neurological disease for testing of bodily fluids for use in disease detection, namely, cancer, precancerous conditions, chronic obstructive pulmonary disease (COPD), autoimmune disease and neurological disease; medical diagnostic kits comprised of medical diagnostic reagents and assays for testing of bodily fluids for use in disease detection, namely, cancer, precancerous conditions, chronic obstructive pulmonary disease (COPD), autoimmune disease and neurological disease in the field of cancer detection or detection, detection of chronic obstructive pulmonary disease (COPD), autoimmune disease and neurological disease; diagnostic reagents for medical purposes
• CC0000: Color is not claimed as a feature of the mark.
• GS0011: Biochemical reagents for non-medical purposes; diagnostic preparations and reagents for scientific or research use; chemical and diagnostic preparations for clinical or medical laboratory use
• GS0441: Consulting services in the field of health; consulting services in the field of diagnostic medical testing; medical analysis for the diagnosis of cancer and chronic obstructive pulmonary disease (COPD) and autoimmune disease and neurological disease and prognosis of expected progression of the diseases; medical testing for diagnostic or treatment purposes in the fields of the detection and treatment of cancer and chronic obstructive pulmonary disease (COPD) and autoimmune disease and neurological disease; providing cancer screening services; providing medical screening services for chronic obstructive pulmonary disease (COPD) and autoimmune disease and neurological disease; providing a website featuring information in the fields of the diagnosis and treatment of cancer and chronic obstructive pulmonary disease (COPD) and autoimmune disease and neurological disease
• GS0101: Medical apparatus for medical diagnostic testing in the fields of cancer or chronic obstructive pulmonary disease (COPD), autoimmune disease and neurological disease
• GS0421: Pharmaceutical research and development; consulting services in the field of biotechnology; consulting services in the field of pharmaceutical research and development; custom design and development of chemical reagents and biochemical assays

Case File Event Statements

• 3/24/2023 - 2 years ago

  1 - NEW APPLICATION ENTERED Type: NWAP

• 4/12/2023 - 2 years ago

  2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS

• 12/13/2023 - a year ago

  3 - ASSIGNED TO EXAMINER Type: DOCK

• 1/4/2024 - a year ago

  4 - NON-FINAL ACTION WRITTEN Type: CNRT

• 1/4/2024 - a year ago

  5 - NON-FINAL ACTION E-MAILED Type: GNRT

• 1/4/2024 - a year ago

  6 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN

• 3/4/2024 - a year ago

  7 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA

• 8/19/2024 - 7 months ago

  10 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME

• 8/19/2024 - 7 months ago

  11 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA

• 8/19/2024 - 7 months ago

  9 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA

• 8/19/2024 - 7 months ago

  8 - ASSIGNED TO LIE Type: ALIE

• 9/4/2024 - 7 months ago

  12 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP

• 9/24/2024 - 6 months ago

  13 - PUBLISHED FOR OPPOSITION Type: PUBO

• 9/24/2024 - 6 months ago

  14 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB

• 11/26/2024 - 4 months ago

  15 - REGISTERED-PRINCIPAL REGISTER Type: R.PR

• 11/26/2024 - 4 months ago

  16 - NOTICE OF REGISTRATION CONFIRMATION EMAILED Type: NRCC